Bio-Rad Laboratories (NYSE:BIO.B) Share Price Passes Below Two Hundred Day Moving Average – Time to Sell?

Bio-Rad Laboratories, Inc. (NYSE:BIO.B) shares crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $324.63 and traded as low as $265.82. Bio-Rad Laboratories shares last traded at $265.82, with a volume of 11 shares changing hands.

Bio-Rad Laboratories Stock Performance

The stock has a market cap of $7.45 billion, a P/E ratio of -4.09 and a beta of 0.75. The firm’s fifty day moving average price is $306.59 and its two-hundred day moving average price is $324.21. The company has a debt-to-equity ratio of 0.18, a current ratio of 6.48 and a quick ratio of 4.85.

Bio-Rad Laboratories (NYSE:BIO.B) last released its quarterly earnings results on Thursday, February 13th. The company reported $2.90 earnings per share for the quarter. Bio-Rad Laboratories had a positive return on equity of 3.90% and a negative net margin of 71.86%.

Bio-Rad Laboratories Company Profile

Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.